Upstate Active Clinical Trials
Study Title:A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy. 20170588
Upstate Institutional Review Board (IRB) Number:1607275
Patient Age Group:Adults
Principal Investigator:Andras Perl, MD, PhD
Who can I contact for more information?
Name: Joanne M Chilton, CCRP